Indolinone combinatorial libraries and related products and methods for the treatment of disease
申请人:——
公开号:US20020102608A1
公开(公告)日:2002-08-01
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
本发明涉及能够调节
酪氨酸激酶
信号转导以调节、调制和/或抑制异常细胞增殖的有机分子。